Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung.

Shibata T, Kokubu A, Miyamoto M, Hosoda F, Gotoh M, Tsuta K, Asamura H, Matsuno Y, Kondo T, Imoto I, Inazawa J, Hirohashi S.

Oncogene. 2010 Aug 19;29(33):4671-81. doi: 10.1038/onc.2010.217. Epub 2010 Jun 14.

PMID:
20543864
2.

ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis.

Fujiwara T, Hiramatsu M, Isagawa T, Ninomiya H, Inamura K, Ishikawa S, Ushijima M, Matsuura M, Jones MH, Shimane M, Nomura H, Ishikawa Y, Aburatani H.

Lung Cancer. 2012 Jan;75(1):119-25. doi: 10.1016/j.lungcan.2011.05.028. Epub 2011 Jul 6.

PMID:
21737174
3.

Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.

Osada H, Tomida S, Yatabe Y, Tatematsu Y, Takeuchi T, Murakami H, Kondo Y, Sekido Y, Takahashi T.

Cancer Res. 2008 Mar 15;68(6):1647-55. doi: 10.1158/0008-5472.CAN-07-5039.

4.

Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.

Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H.

Am J Surg Pathol. 1998 May;22(5):526-37.

PMID:
9591721
5.

Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.

Westerman BA, Neijenhuis S, Poutsma A, Steenbergen RD, Breuer RH, Egging M, van Wijk IJ, Oudejans CB.

Clin Cancer Res. 2002 Apr;8(4):1082-6.

6.

Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis.

Hiroshima K, Iyoda A, Shida T, Shibuya K, Iizasa T, Kishi H, Tanizawa T, Fujisawa T, Nakatani Y.

Mod Pathol. 2006 Oct;19(10):1358-68. Epub 2006 Jul 7.

7.

[Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].

Li F, Zhong Z, Li R, Huang H, Wang L, Zheng D, Zhang D.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):317-21. doi: 10.3779/j.issn.1009-3419.2010.04.09. Chinese.

8.

Transcriptional gene expression profiling of small cell lung cancer cells.

Pedersen N, Mortensen S, Sørensen SB, Pedersen MW, Rieneck K, Bovin LF, Poulsen HS.

Cancer Res. 2003 Apr 15;63(8):1943-53.

9.

hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.

Jiang SX, Kameya T, Asamura H, Umezawa A, Sato Y, Shinada J, Kawakubo Y, Igarashi T, Nagai K, Okayasu I.

Mod Pathol. 2004 Feb;17(2):222-9.

10.

c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.

Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H, Dang CV.

Cancer Res. 2000 Jan 1;60(1):143-9.

11.

Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.

Westerman BA, Breuer RH, Poutsma A, Chhatta A, Noorduyn LA, Koolen MG, Postmus PE, Blankenstein MA, Oudejans CB.

Int J Biol Markers. 2007 Apr-Jun;22(2):114-23.

PMID:
17549667
12.

Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype.

Vos MD, Scott FM, Iwai N, Treston AM.

J Cell Biochem Suppl. 1996;24:257-68.

PMID:
8806108
13.

Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells.

Hellmann GM, Fields WR, Doolittle DJ.

Toxicol Sci. 2001 May;61(1):154-63.

PMID:
11294986
14.

DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer.

Wang J, Sun L, Yang M, Luo W, Gao Y, Liu Z, Qiu X, Wang E.

J Histochem Cytochem. 2013 Jul;61(7):510-21. doi: 10.1369/0022155413488120. Epub 2013 Apr 9.

15.

Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.

Nguyen MH, Koinuma J, Ueda K, Ito T, Tsuchiya E, Nakamura Y, Daigo Y.

Cancer Res. 2010 Jul 1;70(13):5337-47. doi: 10.1158/0008-5472.CAN-09-4372. Epub 2010 Jun 15.

16.

Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors.

Shimakage M, Kodama K, Kawahara K, Kim CJ, Ikeda Y, Yutsudo M, Inoue H.

Oncol Rep. 2009 Jun;21(6):1367-72.

PMID:
19424611
17.

DEK expression in Merkel cell carcinoma and small cell carcinoma.

Patel RM, Walters LL, Kappes F, Mehra R, Fullen DR, Markovitz DM, Ma L.

J Cutan Pathol. 2012 Aug;39(8):753-7. doi: 10.1111/j.1600-0560.2012.01941.x. Epub 2012 Jul 5.

18.

Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.

Ullmann R, Petzmann S, Sharma A, Cagle PT, Popper HH.

Hum Pathol. 2001 Oct;32(10):1059-63.

PMID:
11679939
19.

Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung.

Araki K, Ishii G, Yokose T, Nagai K, Funai K, Kodama K, Nishiwaki Y, Ochiai A.

Lung Cancer. 2003 May;40(2):173-80.

PMID:
12711118
20.

Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.

Meyronet D, Massoma P, Thivolet F, Chalabreysse L, Rogemond V, Schlama A, Honnorat J, Thomasset N.

Am J Surg Pathol. 2008 Nov;32(11):1699-708. doi: 10.1097/PAS.0b013e31817dc37c.

PMID:
18769332

Supplemental Content

Support Center